United States

ENDO 2022

Clinical Implications of Dual Agonist Efficacy Data: Glucose

**Program**
ENDO’s comprehensive program provides attendees the opportunity to learn about the latest developments in hormone science and medicine from renowned investigators, expert clinicians, and educators from all over the world. 

This year’s education program features:
more than 100 in-person and virtual sessions with another 70+ in-person only sessions;
six plenary sessions including plenaries on Envisioning Future Therapies for Type 1 Diabetes and Addressing Challenges in Fertility and Reproduction;
over 20 Meet the Professor sessions presented both in-person and live-streamed virtually and another 20+ presented live in Atlanta;
four Basic Science Pathways, including Diabetes and Metabolism; Neuroendocrinology; Nuclear Receptors and Signaling; and Reproductive Endocrinology; and
more than 30 oral sessions and a robust virtual poster hall for accepted scientific abstracts.

**What Programming Is Included in My Virtual Meeting Registration?**
As you build your schedule during the conference, you can select the sessions that are tagged with 'Livestreamed', so you can view virtually. These sessions are being livestreamed, so they are available in real time to our virtual audience. In addition, our in-person and livestreamed sessions will be recorded, so you can access them on demand after 72 hours. We will have over 200 hours available on demand for Standard and Premium pass registrants.

Product theaters and the Communications and Career Center will also include hybrid content delivery.

**Plenaries**
Spanning the spectrum of science, clinical care, and social implications, an outstanding slate of world-renowned speakers will showcase the most cutting-edge advances on research and medicine.

**Symposia**
Our ENDO 2022 lineup of sessions offers a unique opportunity to dive into topics from nearly every major therapeutic area of endocrinology and hormone science. Listen, learn, and be inspired by world-class faculty who are at the forefront of scientific discovery and high-quality health care.

**Basic Science Pathways**

These special “meeting-within-a-meeting” tracks integrate focused discussions, poster sessions, and networking opportunities to provide you with the latest research in:
Diabetes and Metabolism
Neuroendocrinology
Nuclear Receptors and Signaling
Reproductive Endocrinology

**Meet the Professor & Meet the Scientist**
Discover insights from experts on treating a variety of endocrine conditions and emerging science in the field of endocrinology, and learn the latest in patient care and scientific research.

ENDO’s comprehensive program provides attendees the opportunity to learn about the latest developments in hormone science and medicine from renowned investigators, expert clinicians, and educators from all over the world. 

technical paper

Clinical Implications of Dual Agonist Efficacy Data: Weight and Lipids

Clinical Implications of Dual Agonist Data: Safety, Tolerability, and CV Effects

Why Do So Few People Achieve Weight Loss with Lifestyle Changes Alone?

How Effective are Anti-Obesity Pharmacotherapies? For Weight Loss? For Maintenance?

As Anti-Obesity Pharmacotherapies Become More Widely Used, What is the Role for Bariatric Surgery

What Stigma Have You Experienced as Someone Living with Obesity

What Can We Do About the Significant Weight Stigmatization and Bias among HCPs?

Natural History and Clinical Challenges in Achondroplasia

The Importance of FGFR3 in the Pathophysiology of Achondroplasia and in Emerging Treatments

Best Practices in Collaborative Care and the Potential Impact of Novel Therapies

https://d3smihljt9218e.cloudfront.net/transcript/43124/subtitle/73625645565cbd5007c8ea3df05d4ab1.vtt

English (automatic)

Clinical Implications of Dual Agonist Efficacy Data: Glucose

Downloads

Next from ENDO 2022

Clinical Implications of Dual Agonist Efficacy Data: Weight and Lipids

Similar lecture

Comparison of the Effects of PTH (1-34), PTHrP (1-36) and Abaloparatide (ABL) on the Murine Osteoblast Transcriptome

Stay up to date with the latest Underline news!

PRESENTATIONS

CONFERENCES

COMPANY

RESOURCES